(Total Views: 354)
Posted On: 06/03/2017 7:29:43 AM
Post# of 22998
$CYTR,,, apparently the ASCO presentation was yesterday afternoon
Phase 3 Study of Aldoxorubicin vs Investigator’s Choice as Treatment for Relapsed/Refractory Soft Tissue Sarcomas
Sant Chawla, M.D.
Principal Investigator
Director, Sarcoma Oncology Center Santa Monica, California
Phase 3 Study of Aldoxorubicin vs Investigator’s Choice as Treatment for Relapsed/Refractory Soft Tissue Sarcomas
Sant Chawla, M.D.
Principal Investigator
Director, Sarcoma Oncology Center Santa Monica, California
(0)
(0)
'Everything works out in the end,,,If it hasn't worked out,,it's not the end'
https://twitter.com/twitter/statuses/957208055766241280
https://twitter.com/twitter/statuses/957208055766241280
Scroll down for more posts â–¼
